Yingyi He
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 10
- Acute Myeloid Leukemia Research 8
- Hematopoietic Stem Cell Transplantation 4
- Erythropoietin and Anemia Treatment 2
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- Hui Zhang (11 shared papers)Pengfei Wang (3 shared papers)Hua Jiang (2 shared papers)Zhuoyan Li (1 shared paper)Chunfu Li (5 shared papers)Min Luo (1 shared paper)Wen Yuan Ding (1 shared paper)Jiayi Wang (2 shared papers)
- Journals
- Cancer Medicine (4 papers)Signal Transduction and Targeted Therapy (2 papers)Leukemia (2 papers)Blood (1 paper)BMC Cancer (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yingyi He
31 papers receiving 415 citations
Peers
Comparison fields: 5 of 44
- Oncology 168
- Hematology 91
- Immunology 41
- Public Health, Environmental and Occupational Health 48
- Molecular Biology 72
Countries citing papers authored by Yingyi He
This map shows the geographic impact of Yingyi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingyi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingyi He more than expected).
Fields of papers citing papers by Yingyi He
This network shows the impact of papers produced by Yingyi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingyi He. The network helps show where Yingyi He may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingyi He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 89 | |
| 2 | 2022 | 70 | |
| 3 | 2023 | 42 | |
| 4 | 2021 | 40 | |
| 5 | 2017 | 38 | |
| 6 | 2020 | 32 | |
| 7 | 2020 | 16 | |
| 8 | 2025 | 13 | |
| 9 | 2021 | 12 | |
| 10 | 2014 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2024 | 6 | |
| 13 | 2022 | 5 | |
| 14 | 2011 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2019 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2023 | 3 | |
| 19 | [Expression of human ERMAP gene in fetal tissues]. | 2006 | 2 |
| 20 | [Expression of human ermap gene in umbilical cord blood mononuclear cells during differentiation and development towards erythroid lineage]. | 2008 | 2 |
About Yingyi He
Yingyi He is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Physiology and Immunology, having authored 33 papers that have together received 418 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers), CAR-T cell therapy research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Erythrocyte Function and Pathophysiology (3 papers), Erythropoietin and Anemia Treatment (2 papers), Epigenetics and DNA Methylation (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Oncology (168 citations), Hematology (91 citations), Immunology (41 citations), Public Health, Environmental and Occupational Health (48 citations) and Molecular Biology (72 citations). Yingyi He has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Hui Zhang, Pengfei Wang, Hua Jiang, Zhuoyan Li, Chunfu Li, Min Luo, Wen Yuan Ding, Jiayi Wang, Xu Yang and Xiaoping Liu. Their work appears in journals such as Cancer Medicine, Signal Transduction and Targeted Therapy, Leukemia, Blood and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.